Physician profile
Sigurd Berven
NPI 1336193812
$4,073,660.46
in general payments reported to CMS, 2019-2025
56 companies · $407K in 2025
The $407K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $429K · 2020: $398K · 2021: $376K · 2022: $452K · 2023: $935K · 2024: $1.1M · 2025: $407K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.2M · Consulting Fee: $146K · Travel and Lodging: $43K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Food and Beverage: $13K · Acquisitions: $7,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,172,686.94 |
| Consulting Fee | $146,174.15 |
| Travel and Lodging | $43,366.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,720.00 |
| Food and Beverage | $13,392.56 |
| Acquisitions | $7,342.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,232,089.60 | 2021-2025 | Infuse Bone Graft, Graftonand Grafton Plusdemineralized Bone Matrix (Dbm), Cd Horizon Spinal System |
| Stryker Corporation | $1,271,883.87 | 2019-2025 | Tritanium, Everest Spinal System, N/A |
| Depuy Synthes Products, INC. | $102,956.33 | 2022-2023 | Fibulink |
| Globus Medical, INC. | $80,954.27 | 2019-2023 | Quartex, Excelsiusgps Robotic Navigation System, Caliber |
| Medtronic USA, INC. | $66,071.33 | 2019-2020 | |
| Kyocera Medical Technologies, INC. | $52,956.37 | 2020-2025 | |
| Integrity Implants INC. | $46,926.07 | 2019-2022 | |
| Carlsmed, INC. | $44,133.13 | 2022-2025 | Aprevo |
| Si-Bone, INC. | $28,665.89 | 2019-2025 | |
| Spineology INC. | $25,428.33 | 2021-2024 | Optimesh Expandable Interbody Fusion System |
| Innovasis INC | $24,812.23 | 2019-2023 | |
| Spineart USA INC | $22,170.67 | 2020-2024 | Perla C |
| Renovis Surgical Technologies, INC. | $20,633.28 | 2019 | |
| Camber Spine Technologies LLC | $15,901.80 | 2020-2022 | |
| The Institute of Musculoskeletal Science and Education | $11,119.00 | 2020-2025 | Spira |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novapproach Spine, LLC | $5,168.07 | 2022-2024 | Onelif |
| Osseus Fusion Systems, LLC | $4,668.02 | 2019-2023 | |
| Vb Spine LLC | $3,537.30 | 2025 | Tritanium Pl, Yukon Oct Spinal System |
| Ossdsign USA Incorporated | $3,214.10 | 2025 | Ossdsign Catalyst |
| Kuros Biosciences USA, INC | $1,499.58 | 2019-2023 | |
| Evolution Surgical, INC | $984.90 | 2024 | |
| Philadelphia Medical Management Company LLC | $848.50 | 2022-2023 | Spira-O |
| Orthofix Medical, INC. | $698.15 | 2022-2025 | Mariner, Trinity Elite, Truelok System |
| Kci USA, INC. | $625.00 | 2021 | |
| Alphatec Spine, INC | $583.05 | 2023 | Other - Miscellaneous |
| Medical Device Business Services, INC. | $502.76 | 2022-2024 | Conduit |
| Arthrex, INC. | $475.71 | 2023 | |
| Nuvasive, INC. | $340.63 | 2022-2023 | Reline |
| Depuy Synthes Sales INC. | $324.44 | 2022-2023 | Fibergraft Bg Morsels, Symphony, Expedium |
| 7d Surgical INC. | $317.52 | 2019 | |
| Spineart Sa | $296.04 | 2024 | |
| Sivantage, INC. | $263.09 | 2024-2025 | |
| Curiteva, INC. | $259.84 | 2021 | |
| Spinal Simplicity, LLC | $233.25 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $203.94 | 2023 | Exparel, Iovera, Zilretta |
| Mml US, INC. | $201.42 | 2024 | Reactiv8 |
| Ferring Pharmaceuticals INC. | $200.67 | 2025 | |
| Adcura, INC. | $146.83 | 2023 | |
| Saluda Medical Americas, INC. | $143.00 | 2022 | |
| Spinal Elements, INC. | $136.82 | 2024 | |
| Baxter Healthcare | $121.31 | 2022 | |
| Cerapedics INC. | $119.23 | 2020-2025 | I-Factor Peptide Enhanced Bone Graft |
| Centinel Spine, LLC | $111.79 | 2024 | Prodisc L |
| Arteriocyte Medical Systems, INC. | $100.33 | 2022 | |
| Smith+Nephew, INC. | $94.70 | 2022 | |
| Osteocentric Technologies, INC. | $91.00 | 2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Expanding Innovations, INC. | $81.00 | 2024 | X-Pac |
| Amendia, INC. | $78.00 | 2019 | |
| Medicrea USA, Corp. | $77.88 | 2019 | |
| Spineguard, INC. | $72.48 | 2023 | |
| Sanara Medtech INC. | $45.70 | 2025 | Celleraterx |
| Nexxt Spine LLC | $44.75 | 2024 | Nexxt Matrixx Systems |
| Mighty Oak Medical | $29.99 | 2020 | |
| Biedermann Motech, INC. | $17.50 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,750.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$1,804,880.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sigurd Berven listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.